Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06864689 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.

Study acronym: PrEP
StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Sep 2026 to Oct 31, 2026v5
  2. Start date: Jan 31, 2026 to Sep 2026v4
  3. Start date: Oct 31, 2025 to Jan 31, 2026v3
  4. Primary completion date: Sep 2026 to Aug 2, 2027v2 Show 7 more changesShow less
    • Start date: Jan 31, 2025 to Oct 31, 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Dec 2026 to Aug 31, 2027
    • Eligibility criteria expanded, about 103 words
    • Secondary endpoints revised (3)
    • Site details revised
    • Study description shortened, about 4 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending the HIV Epidemic (EHE) jurisdiction.
Trial Details
NCT Number NCT06864689
Lead Sponsor The University of Texas Medical Branch, Galveston
Collaborators: National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 HIV Prevention
Enrollment 78 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov